| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |